In a record-breaking span of just 11 months, Moderna created, developed, manufactured, and got regulatory authorization for mRNA-1273, a two-dose covid vaccine that is one of the first two mRNA ...

In a record-breaking span of just 11 months, Moderna created, developed, manufactured, and got regulatory authorization for mRNA-1273, a two-dose covid vaccine that is one of the first two mRNA ...

Don't Miss: Today’s deals: $17.50 Apple AirTags, $50 off Madden NFL 25, $30 Crock-Pot Electric Lunch Box, more Produced by Moderna, the proposed vaccine (mRNA-1273) has been in trial for more ...

BioNTech, in collaboration with Pfizer, developed BNT162b2, while Moderna introduced mRNA-1273, each demonstrating over 90% efficacy in clinical trials. These successes catalyzed broader biotech ...

DRS of mRNA-1273 reveals the CCR4–NOT-mediated dynamics of its poly(A) tail in model cell lines. Credit: Nature (2025). DOI: 10.1038/s41586-025-08842-1 ...

The randomized, placebo-controlled trial is expected to include approximately 30,000 participants in the United States, testing an mRNA-1273 dosage of 100 μg. The primary endpoint will be the ...

4/BA.5 and original strains, when compared to mRNA-1273.222. "Moderna blamed after children offered £1,500 to take part in Covid-19 trial " was originally created and published by Clinical Trials ...

and colleagues compared the prevalence of major structural birth defects by COVID-19 vaccination status and compared the prevalence by brand (Moderna mRNA-1273 versus Pfizer-BioNTech BNT162b2 ...